Next Article in Journal
Neural Foundations of Ayres Sensory Integration®
Previous Article in Journal
Effect of a Mental Stimulation Program of Computer and Internet Learning on Cognitive Functions and Wellbeing in Older Community-Dwelling Mexicans
Previous Article in Special Issue
First Case Report of Primary Carnitine Deficiency Manifested as Intellectual Disability and Autism Spectrum Disorder
Article Menu

Export Article

Open AccessBrief Report

Rapid Communication: Plasma Interleukin-35 in Children with Autism

Department of Medical Microbiology and Immunology, and The Medical Investigation of Neurodevelopmental Disorders Institute, University of California, Davis, CA 95817, USA
*
Author to whom correspondence should be addressed.
Brain Sci. 2019, 9(7), 152; https://doi.org/10.3390/brainsci9070152
Received: 31 May 2019 / Revised: 21 June 2019 / Accepted: 24 June 2019 / Published: 27 June 2019
  |  
PDF [596 KB, uploaded 27 June 2019]
  |  

Abstract

In autism spectrum disorders (ASD) many individuals have co-morbid immune dysregulation that can lead to inflammation in the brain and periphery. The novel cytokine interleukin (IL)-35 has described anti-inflammatory properties; however, the plasma levels of IL-35 in children with ASD have never been investigated. The plasma levels of IL-35 were measured by an enzyme-linked immunosorbent assay in 30 children with ASD and 39 typically developing (TD) controls. In the current study, we found that plasma IL-35 levels were significantly decreased in children with ASD compared with TD children. Furthermore, lower IL-35 levels were associated with worse behaviors as assessed using the aberrant behavior checklist. These findings are in line with other observations of decreased regulatory cytokines such as transforming growth factor beta and IL-10 in ASD, and associations with severity of behaviors. In conclusion, regulating the expression of IL-35 may provide a new possible target for the treatment of immune issues in ASD to address an imbalance between pro- and anti-inflammatory signals that alter the behavioral phenotype. View Full-Text
Keywords: autism spectrum disorders; cytokines; immune regulation; interleukin; IL-35; anti-inflammatory autism spectrum disorders; cytokines; immune regulation; interleukin; IL-35; anti-inflammatory
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Rose, D.; Ashwood, P. Rapid Communication: Plasma Interleukin-35 in Children with Autism. Brain Sci. 2019, 9, 152.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Brain Sci. EISSN 2076-3425 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top